Global Bi-Specific MAbS Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028001 No. of Pages: 154 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Bi-Specific MAbS market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Bi-Specific MAbS market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Bi-Specific MAbS in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Catumaxomab
Blinatumomab
Duligotumab
SAR 156597
Market Snapshot, By Application
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others
Main Market Players Analyzed in this report, including:
Thermo Fisher Scientific
Roche
Pfizer
Novartis AG
Mylan N.V.
Merck and Co.
Johnson and Johnson
Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Eli Lilly
Daiichi Sankyo Company
Chugai Pharmaceutical
Bistro-Myers Squibb
Bayer AG
AstraZeneca
Amgen
Abbott
The study objectives of this report are:
To study and analyze the global Bi-Specific MAbS market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Bi-Specific MAbS market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Bi-Specific MAbS manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bi-Specific MAbS market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Bi-Specific MAbS submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Bi-Specific MAbS are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Bi-Specific MAbS Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Bi-Specific MAbS Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Bi-Specific MAbS
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Bi-Specific MAbS Sales Channel and Distributors Analysis
3.3.1 Bi-Specific MAbS Sales Channel
3.3.2 Bi-Specific MAbS Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Cancer
3.4.2 Major Buyers in Autoimmune Diseases
3.5 Bi-Specific MAbS Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Bi-Specific MAbS Type Introduction
4.1.1 Catumaxomab
4.1.2 Blinatumomab
4.1.3 Duligotumab
4.1.4 SAR 156597
4.2 Global Bi-Specific MAbS Sales by Type 2016-2021
4.3 Global Bi-Specific MAbS Revenue by Type 2016-2021
4.4 Global Bi-Specific MAbS Price by Type 2016-2021
5 Market Segment: by Application
5.1 Bi-Specific MAbS Type Introduction
5.1.1 Cancer
5.1.2 Autoimmune Diseases
5.1.3 Inflammatory Diseases
5.1.3 Infectious Diseases
5.1.4 Microbial Diseases
5.1.5 Others
5.2 Global Bi-Specific MAbS Sales by Application 2016-2021
5.3 Global Bi-Specific MAbS Revenue by Application 2016-2021
5.4 Global Bi-Specific MAbS Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Bi-Specific MAbS Market by Region
6.1.1 Global Bi-Specific MAbS Sales by Regions
6.1.2 Global Bi-Specific MAbS Revenue by Regions
6.2 North America Bi-Specific MAbS Market 2016-2021
6.3 Europe Bi-Specific MAbS Market 2016-2021
6.4 Asia Pacific Bi-Specific MAbS Market 2016-2021
6.5 South America Bi-Specific MAbS Market 2016-2021
6.6 Middle East and Africa Bi-Specific MAbS Market 2016-2021
7 North America
7.1 North America Bi-Specific MAbS Market by Country 2016-2021
7.1.1 North America Bi-Specific MAbS Sales by Country
7.1.2 North America Bi-Specific MAbS Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Bi-Specific MAbS Market by Country 2016-2021
8.1.1 Europe Bi-Specific MAbS Sales by Country
8.1.2 Europe Bi-Specific MAbS Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Bi-Specific MAbS Market by Country 2016-2021
9.1.1 Asia Pacific Bi-Specific MAbS Sales by Country
9.1.2 Asia Pacific Bi-Specific MAbS Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Bi-Specific MAbS Market by Country 2016-2021
10.1.1 South America Bi-Specific MAbS Sales by Country
10.1.2 South America Bi-Specific MAbS Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Bi-Specific MAbS Market by Country 2016-2021
11.1.1 Middle East and Africa Bi-Specific MAbS Sales by Country
11.1.2 Middle East and Africa Bi-Specific MAbS Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific
Company Information
12.1.2 Thermo Fisher Scientific
Bi-Specific MAbS Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Scientific
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Scientific
Key Development
12.2 Roche
12.2.1 Roche
Company Information
12.2.2 Roche
Bi-Specific MAbS Product Portfolio, Specification and Application
12.2.3 Roche
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Roche
Key Development
12.3 Pfizer
12.3.1 Pfizer
Company Information
12.3.2 Pfizer
Bi-Specific MAbS Product Portfolio, Specification and Application
12.3.3 Pfizer
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Pfizer
Key Development
12.4 Novartis AG
12.4.1 Novartis AG
Company Information
12.4.2 Novartis AG
Bi-Specific MAbS Product Portfolio, Specification and Application
12.4.3 Novartis AG
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Novartis AG
Key Development
12.5 Mylan N.V.
12.5.1 Mylan N.V.
Company Information
12.5.2 Mylan N.V.
Bi-Specific MAbS Product Portfolio, Specification and Application
12.5.3 Mylan N.V.
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Mylan N.V.
Key Development
12.6 Merck and Co.
12.6.1 Merck and Co.
Company Information
12.6.2 Merck and Co.
Bi-Specific MAbS Product Portfolio, Specification and Application
12.6.3 Merck and Co.
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Merck and Co.
Key Development
12.7 Johnson and Johnson
12.7.1 Johnson and Johnson
Company Information
12.7.2 Johnson and Johnson
Bi-Specific MAbS Product Portfolio, Specification and Application
12.7.3 Johnson and Johnson
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Merck and Co.
Key Development
12.9 GlaxoSmithKline plc
12.9.1 GlaxoSmithKline plc
Company Information
12.9.2 GlaxoSmithKline plc
Bi-Specific MAbS Product Portfolio, Specification and Application
12.9.3 GlaxoSmithKline plc
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 GlaxoSmithKline plc
Key Development
12.8 Hoffmann-La Roche Ltd.
12.8.1 Hoffmann-La Roche Ltd.
Company Information
12.8.2 Hoffmann-La Roche Ltd.
Bi-Specific MAbS Product Portfolio, Specification and Application
12.8.3 Hoffmann-La Roche Ltd.
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Hoffmann-La Roche Ltd.
Key Development
12.11 Daiichi Sankyo Company
12.11.1 Daiichi Sankyo Company
Company Information
12.11.2 Daiichi Sankyo Company
Bi-Specific MAbS Product Portfolio, Specification and Application
12.11.3 Daiichi Sankyo Company
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Daiichi Sankyo Company
Key Development
12.12 Chugai Pharmaceutical
12.12.1 Chugai Pharmaceutical
Company Information
12.12.2 Chugai Pharmaceutical
Bi-Specific MAbS Product Portfolio, Specification and Application
12.12.3 Chugai Pharmaceutical
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Chugai Pharmaceutical
Key Development
12.13 Bistro-Myers Squibb
12.13.1 Bistro-Myers Squibb
Company Information
12.13.2 Bistro-Myers Squibb
Bi-Specific MAbS Product Portfolio, Specification and Application
12.13.3 Bistro-Myers Squibb
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Bistro-Myers Squibb
Key Development
12.14 Bayer AG
12.14.1 Bayer AG
Company Information
12.14.2 Bayer AG
Bi-Specific MAbS Product Portfolio, Specification and Application
12.14.3 Bayer AG
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Bayer AG
Key Development
12.15 AstraZeneca
12.15.1 AstraZeneca
Company Information
12.15.2 AstraZeneca
Bi-Specific MAbS Product Portfolio, Specification and Application
12.15.3 AstraZeneca
Bi-Specific MAbS Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 AstraZeneca
Key Development
12.17 Abbott
13 Global Bi-Specific MAbS Market Forecast by Region by Type and by Application
13.1 Global Bi-Specific MAbS Sales, Revenue Forecast 2022-2027
13.2 Global Bi-Specific MAbS Forecast by Regions
13.2.1 Global Bi-Specific MAbS Sales Forecast by Region 2022-2027
13.2.2 Global Bi-Specific MAbS Revenue Forecast by Region 2022-2027
13.3 Global Bi-Specific MAbS Forecast by Type
13.3.1 Global Bi-Specific MAbS Sales Forecast by Type 2022-2027
13.3.2 Global Bi-Specific MAbS Revenue Forecast by Type 2022-2027
13.3.3 Global Bi-Specific MAbS Price Forecast by Type 2022-2027
13.4 Global Bi-Specific MAbS Forecast by Application
13.4.1 Global Bi-Specific MAbS Sales Forecast by Application 2022-2027
13.4.2 Global Bi-Specific MAbS Revenue Forecast by Application 2022-2027
13.4.3 Global Bi-Specific MAbS Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com